ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers

• Main Authors: SeonJu Park (Author), Raju Das (Author), Nguyen Xuan Nhiem (Author), Sung Baek Jeong (Author), Minuk Kim (Author), Dongguk Kim (Author), Hye In Oh (Author), Su-Hyeon Cho (Author), Oh-Bin Kwon (Author), Jae-Hyeog Choi (Author), Chul Soon Park (Author), Song-Rae Kim (Author), Uk Yeol Moon (Author), Boksik Cha (Author), Dong Kyu Choi (Author), Sungwoo Lee (Author), Wan Namkung (Author), Joohan Woo (Author), Yohan Seo (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Anoctamin 1 (ANO1), a drug target for various cancers, including prostate and oral cancers, is an intracellular calcium-activated chloride ion channel that plays various physiopathological roles, especially in the induction of cancer growth and metastasis. In this study, we tested a novel compound i...